Mallick Parag 4
4 · Nautilus Biotechnology, Inc. · Filed May 12, 2025
Insider Transaction Report
Form 4
Mallick Parag
DirectorChief Scientist10% Owner
Transactions
- Purchase
Common Stock
2025-05-08$0.73/sh+12,000$8,788→ 20,491,892 total - Purchase
Common Stock
2025-05-12$0.73/sh+1,500$1,098→ 20,493,392 total
Footnotes (2)
- [F1]Represents the weighted average share price of an aggregate total of 12,000 shares purchased in the price range of $0.7058 to $0.7520 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 1,500 shares purchased in the price range of $0.7229 to $0.7334 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.